Catasys Inc. (CATS)
(Delayed Data from NSDQ)
$15.45 USD
-0.08 (-0.52%)
Updated May 3, 2019 04:00 PM ET
After-Market: $15.49 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Ontrak, Inc. [CATS]
Reports for Purchase
Showing records 1 - 9 ( 9 total )
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Dropping coverage due to termination of research services
Provider: Taglich Brothers, Inc.
Analyst: NOBILE J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Reiterating Speculative Buy rating and increasing our twelve-month price target to $9.00 per share from $7.50
Provider: Taglich Brothers, Inc.
Analyst: NOBILE J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Reiterating Speculative Buy rating and raising twelve-month price target to $7.50 per share from $5.30 based on strong revenue growth to 2019.
Provider: Taglich Brothers, Inc.
Analyst: NOBILE J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Reiterating Speculative Buy rating but lowering twelve-month price target to $5.30 per share from $8.00 based on our reduced 2018 revenue estimate
Provider: Taglich Brothers, Inc.
Analyst: NOBILE J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
Initiating coverage. with a Speculative Buy rating and twelve-month price target of $8.00 per share
Provider: Taglich Brothers, Inc.
Analyst: NOBILE J
Company: Ontrak, Inc.
Industry: Medical - Outpatient and Home Healthcare
|